Effect of CYP3A5, CYP3A4 and ABCB1 polymorphisms on tacrolimus exposure in renal transplantation patients

被引：0
|
作者：
Ajmi, M. [1 ,2 ]
Sahtout, W. [3 ]
Omezzine, A. [1 ,4 ]
Amor, D. [1 ]
Abderahmene, A. [1 ,4 ]
Azzabi, A. [3 ]
Ben-Rejeb, N. [1 ,4 ]
Achour, A. [3 ]
Bouslama, A. [1 ,4 ]
机构：
[1] Sahloul Univ Hosp, Dept Biochem, LR12SP11, Sousse, Tunisia
[2] Higher Inst Biotechnol Monastir, Sousse, Tunisia
[3] Sahloul Univ Hosp, Dept Nephrol, Sousse, Tunisia
[4] Univ Monastir, Fac Pharm, Sousse, Tunisia
来源：
FUNDAMENTAL & CLINICAL PHARMACOLOGY | 2018年 / 32卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
PS2 - 050
引用
收藏
页码：89 / 89
页数：1
相关论文
共 50 条
  • [1] EFFECT OF CYP3A5, CYP3A4, POR AND ABCB1 POLYMORPHISMS ON TACROLIMUS METABOLISM IN RENAL TRANSPLANT PATIENTS
    Chong, Winnie
    Hamilton-Jones, Siobhan
    Kim, Jon Jin
    Navarrete, Cristina V.
    Key, Tim
    Howell, Martin W.
    HLA, 2020, 95 (04) : 316 - 316
  • [2] Effect of ABCB1 diplotype on tacrolimus disposition in renal recipients depends on CYP3A5 and CYP3A4 genotype
    T Vanhove
    P Annaert
    D Lambrechts
    D R J Kuypers
    The Pharmacogenomics Journal, 2017, 17 : 556 - 562
  • [3] The distribution of genetic polymorphism of CYP3A5, CYP3A4 and ABCB1 in patients subjected to renal transplantation
    Vavic, Neven
    Rancic, Nemanja
    Cikota-Aleksic, Bojana
    Magic, Zvonko
    Cimesa, Jelena
    Obrencevic, Katarina
    Radojevic, Milorad
    Mikov, Momir
    Dragojevic-Simic, Viktorija
    VOJNOSANITETSKI PREGLED, 2016, 73 (07) : 663 - 667
  • [4] Effect of ABCB1 diplotype on tacrolimus disposition in renal recipients depends on CYP3A5 and CYP3A4 genotype
    Vanhove, T.
    Annaert, P.
    Lambrechts, D.
    Kuypers, D. R. J.
    PHARMACOGENOMICS JOURNAL, 2017, 17 (06): : 556 - 562
  • [5] Effect of CYP3A4, CYP3A5, and ABCB1 Polymorphisms on Intravenous Tacrolimus Exposure and Adverse Events in Adult Allogeneic Stem Cell Transplant Patients
    Hamadeh, Issam S.
    Zhang, Qing
    Steuerwald, Nury
    Hamilton, Alicia
    Druhan, Lawrence J.
    McSwain, Meredith
    Diez, Yordanis
    Rusin, Stephanie
    Han, Yimei
    Symanowski, James
    Gerber, Jonathan
    Grunwald, Michael R.
    Ghosh, Nilanjan
    Plesca, Dragos
    Arnall, Justin
    Trivedi, Jigar
    Avalos, Belinda
    Copelan, Edward
    Patel, Jai N.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2019, 25 (04) : 656 - 663
  • [6] Evaluating the Effect of CYP3A4 and CYP3A5 Polymorphisms on Cyclosporine, Everolimus and Tacrolimus Pharmacokinetics in Renal Transplantation Patients
    Moes, D. J. A. R.
    Swen, J. J.
    den Hartigh, J.
    van der Straaten, T.
    van der Heide, Homan J. J.
    Bemelman, F.
    de Fijter, J. W.
    Guchelaar, H. J.
    THERAPEUTIC DRUG MONITORING, 2013, 35 (05) : 672 - 672
  • [7] POLIMORPHISMS IN THE CYP3A4, CYP3A5 AND ABCB1 GENES MODIFY TACROLIMUS PHARMACOKINETICS AND PHARMACODYNAMICS IN RENAL TRANSPLANT
    Garcia, M.
    Macias, R. M.
    Caravaca, F.
    Benitez, J.
    Cubero, J.
    Carrillo, J. A.
    Gervasini, G.
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2011, 109 : 64 - 64
  • [8] Effect of CYP3A5, CYP3A4, and ABCB1 Genotypes as Determinants of Tacrolimus Dose and Clinical Outcomes After Heart Transplantation
    Diaz-Molina, B.
    Tavira, B.
    Lambert, J. L.
    Bernardo, M. J.
    Alvarez, V.
    Coto, E.
    TRANSPLANTATION PROCEEDINGS, 2012, 44 (09) : 2635 - 2638
  • [9] IMPACT OF CYP3A5, CYP3A4, AND ABCB1 GENOTYPES ON TACROLIMUS DOSING AND MONITORING IN LIVER TRANSPLANT PATIENTS
    Ladd, Alexandra
    Pahim, Isabella Angeli
    Warren, Curtis
    Duarte, Sergio
    Zarrinpar, Ali
    HEPATOLOGY, 2022, 76 : S1284 - S1285
  • [10] Early clinical relevance of donor/recipient CYP3A5, CYP3A4 and ABCB1 polymorphisms after liver transplantation under tacrolimus immunosuppression
    Argudo-Ramirez, A.
    Gonzalez De Aledo, J. M.
    Ramirez, P.
    Castellote, J.
    Alia-Ramos, P.
    CLINICA CHIMICA ACTA, 2019, 493 : S641 - S641
12345